According to ECRM’s analysis of circular retail promotions for allergy, Chattem emerged as the leading advertiser of allergy remedies with a 26.8% share of U.S. retail ad support, an increase of 4% over their 2014 promotion share. No surprise there, as Chattem launched Nasacort Allergy 24HR in February 2014.
To view the full OTC Trends Report, click here.